Revilab ML05

Revilab ML05® is a multifunctional drug for the bronchopulmonary system. It contains a unique formula based on synthesised peptides of the immune system (T-cells), peptides of the bronchi and lungs, as well as a powerful vitamin complex.

This effective, fast-acting, new-generation drug has been specially developed for the respiratory system based on synthesised peptides. The drug has a positive effect on the restoration and renewal of the bronchopulmonary system at the cellular level. The high-tech formula contains special short peptides for the bronchopulmonary tree, which accurately reproduce the active centres of proteins from the tissues of young animals.

The action of Revilab® ML05 is based on the synergy of synthesised peptide complexes and natural bronchoprotectors. AA-2 peptides act on the T-cell link of the immune system, which plays a critical role in protecting the respiratory tract from pathogens. T-lymphocytes provide cellular immunity by recognising and destroying infected cells of the bronchial epithelium and alveoli. Healthy T-cell function is especially important for preventing chronic inflammatory processes in the lungs.

The respiratory system is in constant contact with the environment and is exposed to air pollutants, allergens, viruses, and bacteria. The epithelium of the respiratory tract serves as the first line of defence, but its structure is disrupted in chronic inflammation. Frequent colds, prolonged coughing, and shortness of breath during physical exertion may indicate decreased lung function and impaired local immunity.

Bronchial peptides (AA-14) contain specific amino acid sequences that promote the restoration of the ciliated epithelium of the bronchi. Cilia provide mucociliary clearance, an important mechanism for clearing the airways of mucus, dust, and pathogens. In chronic bronchitis, epithelial metaplasia occurs with loss of cilia, which disrupts the self-cleansing of the bronchi and contributes to the stagnation of sputum.

The AA-15 peptide complex from lung tissue supports the function of the alveolar epithelium, the thinnest layer of cells through which gas exchange occurs. Type I alveolar cells ensure the diffusion of oxygen and carbon dioxide, while type II cells produce surfactant, a surface-active substance that prevents the alveoli from collapsing. Emphysema causes destruction of the alveolar walls, which leads to a reduction in the respiratory surface area.

Licorice extract (sweet root) contains glycyrrhizin and glycyrrhetinic acid, compounds with pronounced anti-inflammatory and expectorant properties. Licorice is traditionally used for respiratory diseases because it thins phlegm, relieves coughs and has antiviral properties. Glycyrrhizin is similar in structure to cortisol but does not cause the side effects of hormone therapy.

Omega-3 polyunsaturated fatty acids have anti-inflammatory properties and are particularly important in allergic respiratory diseases. They reduce the production of pro-inflammatory mediators and decrease bronchial hyperreactivity. Omega-3 deficiency is associated with an increased risk of developing bronchial asthma and allergic rhinitis.

Vitamin A (retinol) is necessary for maintaining the integrity of the mucous membranes of the respiratory tract. It participates in the differentiation of epithelial cells and the synthesis of mucins, components of protective mucus. Vitamin A deficiency leads to epithelial metaplasia and increased susceptibility to infections. Vitamin E protects lung tissue from oxidative damage, which is particularly pronounced in inflammatory diseases.

Advantages

Revilab® ML05 provides comprehensive protection and restoration of the bronchopulmonary system at the molecular level. Synthesised peptides activate the body's mechanisms for regenerating the respiratory tract epithelium and stimulate local immunity.

The drug not only eliminates inflammation but also restores the normal structure and function of the bronchi and alveoli. Natural components enhance the expectorant effect and provide powerful antioxidant protection. The drug is effective both for the treatment of acute respiratory diseases and for the prevention of chronic lung diseases.

Its ability to accelerate recovery after severe pneumonia and viral infections, including COVID-19, is particularly valuable.

FIELD OF APPLICATION:

• acute and chronic pneumonia
• acute and chronic bronchitis
• chronic obstructive pulmonary disease (COPD)
• bronchial asthma of various origins
• emphysema
• respiratory allergies and pollinosis
• frequent colds
• sinusitis and tonsillitis
• recovery from COVID-19 and other viral infections
• occupational lung diseases
• rehabilitation after respiratory surgery
• prevention of age-related changes in lung tissue

ACTIVE COMPONENTS:

peptide complex: АА-2 (immune system), АА-14 (peptide of bronchi), АА-15 (peptide of lungs); sweet root extract, polyunsaturated fatty acids omega-3, vitamins: А (retinol), Е.

HOW TO USE AND DOSAGE:

Adults: 1 capsule daily, immediately before meals. Duration of admission 1-2 months.
If necessary, the course of treatment can be repeated throughout the year.

PACKING:

30 capsules by 0,39g. / product: Revilab ML-05 / Non-GMO. Not a medicinal product.